Most sold healthcare stocks in Q3 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q3 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), JOHNSON & JOHNSON (JNJ), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | -3,496,472,296 | -$84.7B | 108 | 479 | 467 | 1679 | 1168 |
| MRK | MERCK & CO. INC. | -1,805,651,478 | -$232.8B | 138 | 649 | 659 | 2195 | 1652 |
| JNJ | JOHNSON & JOHNSON | -1,631,068,328 | -$417.9B | 91 | 881 | 832 | 2576 | 2036 |
| BMY | BRISTOL-MYERS SQUIBB CO | -1,550,803,119 | -$97.9B | 92 | 396 | 363 | 1525 | 999 |
| ABT | ABBOTT LABORATORIES | -1,247,326,073 | -$113.7B | 101 | 477 | 465 | 1767 | 1211 |
| BSX | BOSTON SCIENTIFIC CORP | -1,219,897,556 | -$55.8B | 80 | 167 | 156 | 1049 | 459 |
| ABBV | ABBVIE INC | -1,205,719,410 | -$327.0B | 90 | 773 | 729 | 2339 | 1835 |
| CVS | CVS HEALTH CORP | -1,059,700,428 | -$111.9B | 47 | 281 | 293 | 1317 | 733 |
| GILD | GILEAD SCIENCES INC | -1,030,443,175 | -$131.2B | 103 | 345 | 311 | 1408 | 893 |
| MDT | MEDTRONIC PLC | -1,005,850,804 | -$80.0B | 95 | 348 | 285 | 1327 | 833 |
| VTRS | VIATRIS INC | -990,205,308 | -$15.7B | 34 | 102 | 85 | 706 | 309 |
| MDLN | Medline Inc. | -804,154,151 | -$31.9B | 26 | 29 | 30 | 320 | 94 |
| UNH | UNITEDHEALTH GROUP INC | -728,719,950 | -$304.4B | 79 | 484 | 568 | 2070 | 1288 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -719,611,438 | -$24.3B | 0 | 1 | 2 | 640 | 8 |
| AVTR | AVANTOR INC | -662,798,621 | -$6.4B | 31 | 39 | 24 | 350 | 119 |
| LLY | ELI LILLY & CO | -642,493,251 | -$779.8B | 90 | 924 | 660 | 2640 | 1931 |
| HLN | HALEON PLC-ADR | -552,972,213 | -$5.2B | 25 | 59 | 49 | 449 | 195 |
| ELAN | ELANCO ANIMAL HEALTH INC | -550,675,915 | -$13.6B | 28 | 43 | 32 | 390 | 135 |
| BAX | BAXTER INTERNATIONAL INC | -527,433,949 | -$11.2B | 41 | 68 | 47 | 471 | 225 |
| ROIV | ROIVANT SCIENCES LTD | -527,337,475 | -$18.7B | 35 | 51 | 23 | 384 | 127 |
| DHR | DANAHER CORP | -526,863,774 | -$104.2B | 83 | 263 | 321 | 1348 | 785 |
| EW | EDWARDS LIFESCIENCES CORP | -488,996,401 | -$44.4B | 39 | 144 | 162 | 871 | 449 |
| GERN | GERON CORP | -470,987,343 | -$603.4M | 3 | 13 | 7 | 204 | 47 |
| CNC | CENTENE CORP | -450,978,057 | -$30.0B | 60 | 134 | 78 | 707 | 320 |
| AMGN | AMGEN INC | -408,689,218 | -$147.6B | 121 | 498 | 529 | 1799 | 1373 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -372,547,578 | -$23.9B | 43 | 129 | 127 | 812 | 405 |
| GOSS | GOSSAMER BIO INC | -370,238,576 | -$60.8M | 0 | 0 | 1 | 164 | 1 |
| LXRX | LEXICON PHARMACEUTICALS INC | -363,993,112 | -$873.9M | 3 | 4 | 5 | 125 | 22 |
| ZTS | ZOETIS INC | -356,376,629 | -$25.9B | 53 | 174 | 164 | 985 | 444 |
| RXRX | RECURSION PHARMACEUTICALS-A | -353,253,452 | -$1.3B | 11 | 19 | 16 | 261 | 77 |
| LFST | LIFESTANCE HEALTH GROUP INC | -349,505,854 | -$3.7B | 19 | 27 | 10 | 224 | 71 |
| DXCM | DEXCOM INC | -349,311,734 | -$25.9B | 64 | 99 | 113 | 684 | 322 |
| RPRX | Royalty Pharma Plc | -333,659,516 | -$18.8B | 42 | 61 | 48 | 478 | 181 |
| GSK | GSK PLC-SPON ADR | -327,062,922 | -$17.3B | 33 | 131 | 112 | 673 | 361 |
| MRNA | MODERNA INC | -308,708,417 | -$20.9B | 131 | 72 | 61 | 565 | 311 |
| ALLO | ALLOGENE THERAPEUTICS INC | -305,590,259 | -$640.5M | 7 | 9 | 10 | 172 | 39 |
| TMO | THERMO FISHER SCIENTIFIC INC | -301,534,658 | -$150.0B | 142 | 365 | 421 | 1602 | 1075 |
| TSHA | TAYSHA GENE THERAPIES INC | -297,065,125 | -$2.0B | 3 | 13 | 4 | 178 | 28 |
| LAB | STANDARD BIOTOOLS INC | -286,956,206 | -$236.8M | 1 | 2 | 5 | 128 | 11 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -285,744,685 | -$14.6B | 42 | 128 | 184 | 897 | 449 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -280,683,514 | -$1.1B | 16 | 20 | 16 | 226 | 66 |
| ISRG | INTUITIVE SURGICAL INC | -277,961,301 | -$111.3B | 75 | 353 | 267 | 1449 | 796 |
| ERAS | ERASCA INC | -274,313,339 | -$5.0B | 7 | 16 | 8 | 214 | 35 |
| SHC | SOTERA HEALTH CO | -274,219,680 | -$4.9B | 14 | 31 | 8 | 249 | 66 |
| BKD | BROOKDALE SENIOR LIVING INC | -260,599,857 | -$4.2B | 8 | 8 | 11 | 245 | 38 |
| SYK | STRYKER CORP | -258,631,035 | -$83.9B | 56 | 294 | 352 | 1411 | 828 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -248,527,301 | -$2.5B | 6 | 20 | 14 | 256 | 53 |
| A | AGILENT TECHNOLOGIES INC | -243,823,218 | -$32.8B | 69 | 125 | 110 | 768 | 393 |
| EXEL | EXELIXIS INC | -242,216,785 | -$13.3B | 39 | 73 | 68 | 544 | 220 |
| RLAY | RELAY THERAPEUTICS INC | -241,862,553 | -$4.5B | 4 | 14 | 6 | 215 | 34 |